Correvio Pharma Corp. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Correvio Pharma Corp. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of 4.38 CAD/shares as of 2014-12-31, per its 40-F filed 2015-03-27.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2015-03-27
- 2014-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price 4.38 CAD/shares.
- 2013-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price 6.18 CAD/shares.
- 2012-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price 3.97 CAD/shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2014-12-31 | 4.38 CAD/shares 40-F · filed 2015-03-27 |
| 2013-12-31 | 6.18 CAD/shares 40-F/A · filed 2014-04-30 |
| 2012-12-31 | 3.97 CAD/shares 20-F/A · filed 2013-04-18 |